David A. Harris, MD, PhD - Highly Synergistic Combination Therapy for Prion Diseases
Meet David Harris, MD
John E. Harris, MD, PhD - VIS 2020 Invited Speaker
The global case of end-stage kidney disease by David Harris
#140 - Gerald Shulman, MD, PhD: Insulin resistance—molecular mechanisms and clinical implications
2016 SID Naomi M Kanof Lecture, Roger Perlmutter, MD, PhD
VitiTalks - Part 1 Dr. John Harris, MD, PhD
Galien Forum USA 2018 / Novel Approaches to Combating Opioid Addiction
Part 3: The State of Men's Health. The Path Forward
Dr. David Geller: Limb Salvage Surgery in Children
VitiTalks Part 2 with Dr. Brett King, MD, PhD
Demystifying Glaucoma IV: The Journey That is Glaucoma with Dr. David Tingey, MD, FRCSC(C)
Jung Min Bae, MD, PhD - 2021 GVF Annual Scientific Symposium
2022 Educational Update Alzheimers Session
See Spots Disappear: JAK Inhibitors in Vitiligo and Beyond
Cardiogenic Shock and Hemodynamics of Mechanical Circulatory Support | Daniel Burkhoff, MD, PhD
David G. Kirsch, MD, PhD, Damon Runyon Scientist
Day 1 Coordination and Messaging: from the Hospital to the Community
Highlights from the Symposium "Comeback of psychedelic drugs in science and medicine", 30 Oct 2015
Accounts of Rapid Testing (E8.P2) Covid-19 The Answers - Prof David Harris PhD, Dr Funmi Okunola MD
